Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03787030Phase 3Completed
Phase 3, randomised, open-label trial of alpha-tocopherol in chronic anal fissure (CAF), sponsored by Hospital General Universitario de Elche. Primary endpoint: Pain associated to anal fissure at 8 weeks. Started Dec 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03787030.